Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Breast Neoplasms 14Prostatic Neoplasms 12Multiple Myeloma 8Neoplasm Metastasis 6Osteoporosis 4Carcinoma, Renal Cell 3Carcinoma, Non-Small-Cell Lung 3Ovarian Neoplasms 2Neoplasms, Plasma Cell 2Lung Neoplasms 2Kidney Neoplasms 2Bone Diseases 2Uterine Cervical Neoplasms 1Urologic Neoplasms 1Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pleural Effusion, Malignant 1Pancreatic Neoplasms 1Osteonecrosis 1Oligodendroglioma 1Neovascularization, Pathologic 1Neoplasms by Site 1Neoplasms 1Neoplasm, Residual 1Neoplasm Micrometastasis 1Nasopharyngeal Neoplasms 1Myelodysplastic Syndromes 1Mesothelioma 1Lymphoma 1

Interventions

Temozolomide 29Bevacizumab 12Radiotherapy 10Irinotecan 7Carboplatin 7Carmustine 5Magnetic Resonance Spectroscopy 4Filgrastim 4Cyclophosphamide 4Cisplatin 4Vincristine 3Thiotepa 3Surgical Procedures, Operative 3Peripheral Blood Stem Cell Transplantation 3Etoposide 3talampanel 2sargramostim 2antineoplaston AS 2-1 2antineoplaston A10 2abemaciclib 2Topotecan 2Thalidomide 2Tamoxifen 2Sunitinib 2Radiotherapy, Intensity-Modulated 2Procarbazine 2Immunoglobulin G 2Everolimus 2Drug Therapy 2Doxorubicin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Oligodendroglioma × Zoledronic Acid × Clear all
NCT00301873 2013-02-18

Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma

Duke University

Phase 2 Completed
60 enrolled 10 charts
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Osteoporosis, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡